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ATP binding cassette (ABC) transporters are a diverse
superfamily of energy-dependent membrane translo-
cases. Although responsible for the majority of trans-
membrane transport in bacteria, they are relatively un-
common in eukaryotic mitochondria. Organellar traf-
ficking and import, in addition to quaternary structure
assembly, of mitochondrial ABC transporters is poorly
understood and may offer explanations for the paucity
of their diversity. Here we examine these processes in
ABCB10 (ABC-me), a mitochondrial inner membrane
erythroid transporter involved in heme biosynthesis.
We report that ABCB10 possesses an unusually long 105-
amino acid mitochondrial targeting presequence (mTP).
The central subdomain of the mTP (amino acids (aa)
36–70) is sufficient for mitochondrial import of en-
hanced green fluorescent protein. The N-terminal sub-
domain (aa 1–35) of the mTP, although not necessary for
the trafficking of ABCB10 to mitochondria, participates
in the proper import of the molecule into the inner mem-
brane. We performed a series of amino acid mutations
aimed at changing specific properties of the mTP. The
mTP requires neither arginine residues nor predictable
-helices for efficient mitochondrial targeting. Disrup-
tion of its hydrophobic character by the mutation L46Q/
I47Q, however, greatly diminishes its efficacy. This mu-
tation can be rescued by cryptic downstream (aa 106–
715) mitochondrial targeting signals, highlighting the
redundancy of this protein’s targeting qualities. Mass
spectrometry analysis of chemically cross-linked, immu-
noprecipitated ABCB10 indicates that ABCB10 embed-
ded in the mitochondrial inner membrane homodimer-
izes and homo-oligomerizes. A deletion mutant of
ABCB10 that lacks its mTP efficiently targets to the
endoplasmic reticulum. Quaternary structure assembly
of ABCB10 in the ER appears to be similar to that in the
mitochondria.
ABC1 transporters comprise a large and diverse family of
membrane translocases (1). Their function ranges from peptide
transport to phospholipid flipping to anion channel formation.
Members of the ABC transporter superfamily have been impli-
cated in numerous human diseases (including cystic fibrosis
(CFTR/ABCC7), adrenoleukodystrophy (ALDP/ABCD1), Zell-
weger’s syndrome (PMP70/ABCD3), progressive familial intra-
hepatic cholestasis (SPGP/ABCB11), and Stargardt macular
dystrophy (ABCR/ABCA4)) (2). The basic structure of ABC
transporters is relatively well conserved and includes a hydro-
philic ATP binding cassette and a hydrophobic membrane-
spanning domain (3). Whereas the large members of the family
contain two of each domain, the “half-transporters” contain one
of each and are predicted to dimerize (3–6). Mammalian ABC
transporters are found predominantly in the plasma mem-
brane but are also known to play essential roles in a number of
organelles, including the endoplasmic reticulum, peroxisome,
and the mitochondrion (2). Mammalian mitochondrial ABC
transporters have recently gained attention for their role in
heme biosynthesis and iron sulfur cluster synthesis (7–12).
Accordingly, their involvement in the pathophysiology of ac-
quired and inherited forms of sideroblastic anemias has been
suggested and, in the case of ABCB7, already demonstrated.
Only eight mitochondrial ABC transporters have been de-
scribed to date (7). This is remarkable, given that in bacteria,
ABC proteins are the most diverse family of transporters, num-
bering well over 50 in Escherichia coli. Since mitochondrial
ABC transporters are synthesized in the cytosol, they require
proper trafficking, import, and assembly to achieve functional-
ity in their target organelle.
Two dominant mitochondrial import pathways have been
described, each involving specialized import machinery and
distinct signals (13). One pathway recognizes a cleavable, N-
terminal mitochondrial targeting presequence (mTP) and is
generally utilized by hydrophilic proteins. The second pathway,
employed by the membrane metabolite carrier class of proteins,
is used by more hydrophobic proteins bearing internal target-
ing signals. mTPs, although they lack a consensus primary
sequence, share a number of common characteristics. They are
rich in arginine residues, feature a net positive charge, and
possess amphiphilic -helices (14–17). Additionally, some
mTPs include a short hydrophobic motif that is recognized by
Tom20, a component of the mitochondrial import machinery on
the outer membrane (18, 19). mTPs lead their preproteins into
the matrix in a linear configuration, where they are cleaved off
by the mitochondrial processing peptidase, allowing for final
assembly of the mature protein in one of the mitochondrion’s
compartments (20). Proteins of the metabolite carrier class do
not possess a cleavable presequence (21, 22). Rather, they bear
three internal targeting modules that cooperatively bind to
Tom70. These proteins are transported in a loop configuration
directly into the inner membrane, where they assume their
functional structure (23).
ABC half-transporters include a 200-amino acid hydro-
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philic ATP binding cassette and a 400-amino acid hydropho-
bic transmembrane domain. Therefore, these proteins might
present a challenge to mitochondrial import machinery. This
study marks the first comprehensive analysis of the mitochon-
drial targeting, import, and assembly properties of an ABC
transporter. We have previously reported on the murine mito-
chondrial transporter, ABCB10 (ABC-me). ABCB10 is induced
during erythroid differentiation and is involved in heme bio-
synthesis (8). We report here that the ABCB10 preprotein
includes an unusually long mTP of 105 residues that provides
mitochondrial targeting redundancy and flexibility. Point mu-
tation experiments reveal that ABCB10 additionally possesses
downstream (aa 106–715) targeting signals capable of assist-
ing a damaged mTP. To differentiate between protein traffick-
ing and protein import, we combined confocal microscopy of
living cells and biochemical analysis of isolated organelles. We
show that removing part of the mTP of ABCB10 results in
efficient trafficking but compromised import into the mitochon-
dria. Quaternary structure analysis of ABCB10 indicates that
it homo-oligomerizes in the mitochondrial inner membrane and
does not appear to assemble with other proteins. ABCB10 that
lacks its mTP is targeted not to mitochondria but to the ER,
where it also oligomerizes.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection—HEK 293T and COS cells were cul-
tured in low glucose DMEM without phenol red (Invitrogen) supple-
mented with 10% standard fetal bovine serum (Hyclone, Logan, UT), 2
mM L-glutamine (Invitrogen), and antibiotics at 37 °C in 5% CO2, 95%
air atmosphere. G1ER cells (24) were grown in Iscove’s modified Dul-
becco’s medium (Invitrogen) supplemented with 15% heat-inactivated
fetal calf serum, 2 units/ml Epoetin  (Amgen, Thousand Oaks, CA),
0.5% Chinese hamster ovary kit ligand (stem cell factor) conditioned
medium (100 units/ml), and antibiotics. Transient transfections of HEK
293T cells and COS cells were performed using FuGene 6 (Roche Ap-
plied Science) according to the manufacturer’s instructions. Cells were
15% confluent at transfection. Transfection efficiency was 70%.
Plasmids and DNA Constructs—The 105-aa mTP of mouse ABCB10
and its five wild-type subdomains (aa 1–35, 36–70, 71–105, 1–70, and
36–105) were prepared by PCR using primers containing an EcoRI
restriction site followed by a Kozak initiation sequence at the 5-end
and a BamHI restriction site at the 3-end, using ABCB10 as template.
Single amino acid mutations were performed by triple PCR, with mul-
tiple mutations achieved with additional rounds. Amplified fragments
were digested and cloned into pEGFP-N1 vector (Clontech, Palo Alto,
CA) with T4 DNA ligase (Roche Applied Science) using the EcoRI (5)
and BamHI (3) restriction sites upstream to EGFP. Deletion constructs
were also prepared by PCR. All constructs were validated by sequencing
at the core facility at either Children’s Hospital or Tufts University
(Boston, MA).
Labeling of the Mitochondria and Endoplasmic Reticulum (ER), Con-
focal Microscopy, and Data Analysis—Mitochondria were labeled using
the mitochondria-specific dyes tetramethylrhodamine ethyl ester per-
chlorate (TMRE) and Mitotracker Red CMH2Xros from Molecular
Probes, Inc. (Eugene, OR). Freshly prepared TMRE was added to cul-
ture in Me2SO (Fisher) at 50 nM and incubated for 10 min prior to
visualization. Cells were kept in the dark and examined for a maximum
of 15 min. Mitotracker Red was applied to culture at 100 nM, also in
Me2SO. The cells were incubated for 30 min and washed twice in warm
culture medium. Mitotracker Red was used to verify the precise mito-
chondrial labeling of TMRE. The ER was labeled using the ER-specific
dye ER-Tracker™ blue-white DPX (E-12353) at a concentration of 100
nM as directed by the manufacturer (Molecular Probes).
Confocal microscopy was performed on live cells in glass slide bottom
dishes (MatTek, Ashland, MA) using a Zeiss LSM 510 Meta microscope
with a 63 oil immersion objective at 37 °C. Using multitrack analysis,
red-emitting mitochondrial dyes were excited with a 543-nm helium/
neon laser, and emission was recorded through a BP 650–710-nm filter.
EGFP was excited using a 488-nm argon laser, and emission was
recorded through a BP 500–550-nm filter. ER-Tracker blue-white DPX
(E-12353) was excited with a two-photon laser, and emission was re-
corded through a BP 435–487-nm filter.
The correlation plot application of Metamorph image analysis soft-
ware version 5.0 was employed for colocalization quantification and
generation of scatter plots. 12–24 cells from a minimum of 8–12 colonies
were analyzed per condition. Colocalization was analyzed for individual
cells identified as regions of interest. They were averaged for each
condition to determine a mean mitochondrial correlation coefficient
(MMCC), and the S.E. was calculated. Relative significance of data sets
was determined by a standard t test with the threshold set at p  0.05.
Isolation of Mitochondria—Crude mitochondria were prepared by
differential centrifugation as described (8). Density gradient purifica-
tion was performed using OptiPrep™ as directed by the manufacturer
(Axis-Shield, Oslo, Norway). The Bradford assay was used to spectro-
photometrically determine the protein concentration using a Nano-
Drop ND-1000 UV-visible spectrophotometer (NanoDrop Technologies,
Rockland, DE).
Protein Cross-linking and Immunoprecipitation—1,5-Difluoro-2,4-di-
nitrobenzene (DFDNB; Pierce) dissolved in Me2SO was used as the
cross-linking reagent at a concentration of 30 g/30 g of protein for low
level and 300 g/30 g of protein for high level cross-linking. Gradient-
purified mitochondria were suspended in 150 mM KCl and incubated in
DFDNB at 0 °C for 30 min. The reaction was quenched at 25 °C for 30 s
with 400 mM Tris base (pH 9). Cross-linking was also performed on
whole cell lysate using a modified protocol in which the cells were
resuspended in phosphate-buffered saline supplemented with Com-
plete™ EDTA-free protease inhibitor (Roche Applied Science) and
flash-frozen in liquid nitrogen to break the membranes. Cross-linking
was performed as stated above, with the addition of 120 g/ml DNase I
(Roche Applied Science) during quenching. Immunoprecipitation was
performed using Protein G-agarose beads (Roche Applied Science) and
anti-V5 (1:500 dilution) (Invitrogen) and anti-c-Myc (1:500 dilution)
(Invitrogen) antibodies as described (25).
One-dimensional SDS-PAGE, Silver Staining, and Western Blot-
ting—Mitochondrial samples were taken up in sample buffer (62.5 mM
Tris, 10% glycerol, 2% SDS, 1% Triton X-100, 2.5% -mercaptoethanol,
bromphenol blue), loaded on a 4–15% gradient Tris-HCl gel (Bio-Rad),
and electrophoresed at 160 V in running buffer using a Bio-Rad Mini-
Protean 3 cell. Proteins to be identified by MS/MS analysis were re-
vealed by silver staining using the Silver Stain Plus kit (Bio-Rad).
For detection by Western blotting, proteins were transferred onto
nitrocellulose or polyvinylidene difluoride membrane using a Bio-Rad
TransBlot SD rapid transfer cell in Towbin buffer at 140 mA for 1 h at
room temperature. Primary antibodies were anti-EGFP (1:2500 dilu-
tion) (Clontech) and anti-V5-horseradish peroxidase (1:5000 dilution)
(Invitrogen). Protein was revealed using a Super Signal chemilumines-
cent horseradish peroxidase detection system as directed by the man-
ufacturer (Pierce) and exposed to Kodak BioMax MR film (Eastman
Kodak Co.).
Mass Spectrometry and N-terminal Sequencing—Protein identifica-
tion of SDS-PAGE silver-stained bands was done by MS/MS analysis of
tryptic peptides using the MS-fit program as previously described (26).
N-terminal protein sequencing was performed by automated Edman
degradation on an Applied Biosystems model 494 Procise sequencer.
Samples separated by SDS-PAGE were transferred onto polyvinylidene
difluoride membrane and stained with Coomassie Blue. Model 610A
version 2.1 software was employed for data acquisition and processing.
Proteinase K Digestion of Extramitochondrial Proteins—Extramito-
chondrial protein digestion was carried out to verify complete mitochon-
drial insertion of each mTP and its passenger protein. It was performed
on all constructs that targeted partially or entirely to mitochondria.
Those constructs that targeted to mitochondria but were not fully
imported are mentioned under “Results.” To accomplish extramitochon-
drial protein digestion, gradient-purified mitochondria were incubated
with 100 g/ml proteinase K (Sigma) on ice for 30 min. Proteinase K
was subsequently inactivated using a modified procedure described by
Glick (27). Briefly, 2 mM phenylmethylsulfonyl fluoride (Pierce) was
added, and the mitochondria were pelleted by centrifugation at
17,500  g for 10 min at 4 °C. Mitochondria were resuspended in buffer
C (0.6 M sorbitol (Fisher), 20 mM HEPES, pH 7.4) supplemented with
2 Complete™ protease inhibitor mixture (Roche Applied Science), 2
mM phenylmethylsulfonyl fluoride, and 5.5% (v/v) trichloroacetic acid
(Sigma), heated to 70 °C for 5 min, and then incubated on ice for an
additional 5 min. Mitochondria were reisolated by centrifugation at
12,000  g for 10 min and immediately resuspended in sample buffer
for separation by one-dimensional SDS-PAGE. 2 M Tris, pH 9, was
added dropwise to neutralize the solution.
Whole Cell Protein Analysis—Whole cell protein analysis was per-
formed to control for post-translational stability of transfected con-
structs. The procedure was carried out on all constructs that did not
target to mitochondria. Those constructs that were cleaved prior to
mitochondrial targeting, thus reducing targeting efficiency, are men-
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tioned under “Results.” For whole cell protein analysis, cells were lysed
in buffer C, supplemented with 0.1% (v/v) SDS and 2 M pepstatin A
(Roche Applied Science) to prevent protein degradation. Protein was
then precipitated using 5.5% (v/v) trichloroacetic acid and immediately
separated by SDS-PAGE.
RESULTS
Identification of ABCB10 Presequence Cleavage Site—
ABCB10 fused to V5 at its C-terminal was expressed in HEK
293T cells, immunoprecipitated, and separated by SDS-PAGE.
Silver staining revealed a band at65 kDa (Fig. 1A). This band
was subjected to tryptic fragment analysis by tandem mass
spectrometry and was identified as ABCB10, with the frag-
ments obtained indicating that a larger than expected portion
of the N terminus could be missing (data not shown). N-termi-
nal sequencing performed on the band identified the first 17
amino acids as LGNDSQRRPAATGRSEV, which correspond to
ABCB10 aa 106–123 (Fig. 1B). The 105-aa mTP of ABCB10 is
unusually long compared with the mean mTP length of 34
residues  17 (one S.D.) (28).
The mTP of ABCB10 Is Necessary for Mitochondrial Import
of ABCB10 and Sufficient for Import of EGFP—To explore the
mitochondrial targeting and import properties of ABCB10 and
its mTP, EGFP was fused at their C termini, and the proteins
were expressed in HEK 293T cells. Their colocalization with
mitochondria stained with TMRE was analyzed by confocal
microscopy (Fig. 2). Metamorph image analysis software gen-
erated per-pixel scatter plots of red and green signal intensi-
ties. The MMCC is a measure of the scatter plot’s tendency for
positive linear correlation. Thus, a value of 1 represents
perfect mitochondrial colocalization, 0 represents no mitochon-
drial preference, and 1 represents perfect mitochondrial ex-
clusion. Since HEK 293T fibroblasts grow in adherent colonies,
cells were selected from at least 12 colonies to minimize the
impact of clonal variation. EGFP has been employed previously
for similar subcellular localization studies (18, 29). EGFP alone
is cytosolically localized and shows no organellar preference
(Fig. 2E). EGFP carries consecutive negative charges at resi-
dues 6E and 7E of the EGFP molecule. Concentrated negative
charge is highly unfavorable to mitochondrial targeting (16).
Therefore, it is believed that C-terminal EGFP fusion does not
enhance mitochondrial targeting of a molecule.
As expected, ABCB10-EGFP co-localizes with mitochondria,
giving an MMCC of 0.81  0.02 (Fig. 2A). The mTP of ABCB10
alone also targets EGFP to the mitochondria, demonstrating its
sufficiency as an mTP. The MMCC for aa 1–105-EGFP is 0.81 
0.02 (Fig. 2B). To ensure that these proteins were fully imported
into mitochondria, in addition to their being trafficked to the
mitochondrial surface, biochemical analysis of their position was
performed. Density gradient-purified mitochondria were isolated
from HEK 293T expressing the protein of interest. Mitochondria
were then subjected to proteinase K digestion of extramitochon-
drial proteins, and the results were analyzed by Western blot-
ting. Western blots of aa 1–105-EGFP pre- and postdigestion
were identical, indicating that complete import was accom-
plished (data not shown). This validation procedure was carried
out on all subsequently examined constructs that targeted to
mitochondria (see “Experimental Procedures”).
Removal of the mTP from ABCB10-EGFP drastically reduces
mitochondrial targeting, resulting in an MMCC of 105-
ABCB10-EGFP of 0.33  0.03 (Fig. 2C). For experimental
control, mitochondrial targeting was additionally calculated for
EGFP C-terminally fused to a standard, commercially avail-
able mTP, subunit VIII of human cytochrome c oxidase (Clon-
tech), and EGFP alone (Fig. 2, D and E). The negative MMCC
for EGFP alone indicates that it avoids mitochondria. To en-
sure that the failure of 105-ABCB10-EGFP to target to mito-
chondria was not due to post-translational cleavage, cell lysate
was prepared and analyzed by Western blotting with anti-
EGFP. All 105-ABCB10-EGFP that was detected appeared at
an apparent molecular weight consistent with the predicted
value (data not shown). This procedure was carried out on all
subsequently examined constructs that failed to efficiently tar-
get to mitochondria (see “Experimental Procedures”).
Removal of the mTP Results in the Mistargeting of ABCB10
to the ER—105-ABCB10-EGFP does not appear ubiquitously
in the cytoplasm but rather is identified as a meshlike struc-
ture characteristic of the ER membrane (Fig. 2C). Cells ex-
pressing 105-ABCB10-EGFP were co-stained with the ER-
specific dye ER-Tracker blue-white DPX (E-12353) and
subjected to ER colocalization quantification according to the
same technique as mitochondrial colocalization (Fig. 2F). 105-
ABCB10-EGFP is targeted into the ER with high efficiency,
suggesting that an alternative subcellular distribution of
ABCB10 or isoforms of ABCB10 may exist. Subcellular local-
ization of 105-ABCB10 was additionally examined in COS
cells, yielding identical ER preference (data not shown).
Fragmentation of the mTP of ABCB10 and Identification of a
Critical Targeting Region—The primary amino acid sequence
FIG. 1. The mTP of ABCB10. A, silver stain of immunoprecipitated
ABCB10 isolated from mitochondria of HEK 293T cells transfected with
ABCB10-V5. Lane 1, negative control of immunoprecipitation (IP) using
anti-c-Myc antibody. Lane 2, immunoprecipitation using anti-V5 anti-
body. A band (verified as ABCB10-V5 by mass spectrometry) appears at
65 kDa (indicated by an arrow). An artifact of immunoprecipitation
appears in both lanes at55 kDa. ABCB10-V5 was excised from the gel
and subjected to N-terminal sequencing. B, the first 123 amino acids of
ABCB10 and the position of the protein in the mitochondria. N-terminal
sequencing of mature protein identified the first 17 amino acids as
LGNDSQRRPAATGRSEV, corresponding to Leu106–Val123, indicating
that the mTP is composed of aa 1–105. Basic residues are in boldface
type, and acidic residues are in gray. Predicted -helices are underlined.
Note that the hydrophobic transmembrane domain (TMD) and hydro-
philic nucleotide binding domain (NBD) each represent large fractions
of the imported protein.
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(Fig. 1B) and predicted secondary structure of the mTP of
ABCB10 were examined for features characteristic of mTPs.
The distribution of both positive charge and hydrophobic mo-
ment (a measure of amphiphilicity) along the mTP of ABCB10
follows a pattern that delineates three distinct subdomains
(Fig. 3, A and B). Similarly, the three putative -helices are
FIG. 2. The 105-aa mTP of ABCB10 is sufficient and necessary to import ABCB10-EGFP into mitochondria. Confocal microscopy of
EGFP colocalization with mitochondria was used to analyze the mitochondrial targeting of ABCB10 and its mTP. Red, TMRE, a mitochondria-
specific dye; green, EGFP, which is fused to the C-terminals of all constructs. Colocalization appears yellow and orange in the merged frames.
Scatter plots plot each pixel according to its green and red intensities, green on the x axis and red on the y axis. MMCC was calculated for each
construct using 12–24 cells. Proteins that target to mitochondria at significantly lower efficiency than wild-type ABCB10 are indicated with an
asterisk. Representative cells are displayed. Bars, 20 m. A, wild-type ABCB10; excellent mitochondrial targeting. B, mTP alone is sufficient for
mitochondrial targeting. C, 105-ABCB10 is not targeted to mitochondria but rather to an alternate structure. D, positive control; EGFP fused to
the commercially available mTP of COXVIII. E, negative control; EGFP lacking a targeting peptide is ubiquitously distributed throughout the cell.
F, 105-ABCB10 colocalizes well with ER-tracker dye (white); scatter plot displays green on the x axis and white on the y axis.
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FIG. 3. Targeting of the subdomains of the mTP of ABCB10 and role of aa 1–35 in mitochondrial import of ABCB10. A, plot of charge
distribution along the mTP of ABCB10. A sliding window of 12 aa was used to calculate average charge. B, hydrophobic moment plot of the mTP
calculated according to Eisenberg’s algorithm using a -angle of 100° and a consensus hydrophobicity scale, a measure of amphiphilicity. Note the
presence of three regions of the mTP, each containing a maximum in positive charge, a peak in hydrophobic moment, and a single predicted -helix.
C–E, the central subdomain is as effective at targeting EGFP to mitochondria as the entire mTP. aa 1–35 and 71–105 demonstrate reduced
mitochondrial targeting compared with the entire mTP. An asterisk indicates significant difference. F and G, removal of aa 1–35 from the mTP and
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dispersed one per subdomain (Fig. 1B). To investigate under-
lying independent functionality of the three subdomains, frag-
mentation and mutation experiments were performed. The
mTP was divided into three 35-aa fragments: aa 1–35, 36–70,
and 71–105. The two negatively charged residues of the mTP of
ABCB10 are located in positions 35 and 105, the C-terminal
residues on the first and third fragments, respectively. Their
proximity to EGFP minimizes their effect on the targeting
properties of the mTP. Since the average length of all con-
firmed mTPs is 34 aa, the targeting efficiency of the fragments
is not compromised by mTP length alone (28). Thus, examina-
tion of the targeting of the mTP fragments offers insight into
the inherent properties in each region.
The central 35 aa of the mTP of ABCB10 is more effective at
targeting EGFP to mitochondria than the flanking subdomains
(Fig. 3). aa 1–35 and 71–105 only partially target EGFP to the
mitochondria (MMCC of 0.50  0.04 and 0.50  0.05, respec-
tively). aa 36–70 targets EGFP to the mitochondria as effi-
ciently as the entire mTP of ABCB10 (Figs. 2B and 3D). aa
1–70, which is expected to target to mitochondria well, has a
low MMCC of 0.27  0.05 (data not shown). However, Western
blot analysis of cell lysate found that the protein is unstable
(Fig. 3H). Ambiguous cleavage events free EGFP from the rest
of the protein, thereby causing EGFP to localize to the cyto-
plasm. A similar process occurred when aa 36–70 alone was
N-terminally fused to 105-ABCB10-EGFP to determine the
capacity of the isolated central subdomain of the mTP to target
ABCB10 to the mitochondria. The resulting protein was unsta-
ble in both HEK 293T cells and COS cells (data not shown).
Functional Analysis of aa 1–35: Evidence for a Role in the
Translocation of ABCB10 across Mitochondrial Membranes—
The N-terminal subdomain of the mTP, aa 1–35, is not essential
for the trafficking of ABCB10 to mitochondria. Both aa 36–105-
EGFP and 35-ABCB10-EGFP are brought to the mitochondrial
surface (Fig. 3, F and G). Western blot analysis suggested, how-
ever, that35-ABCB10-V5 is not fully inserted into mitochondria
despite reaching their outer membranes. Western blot analysis of
density gradient-purified mitochondria was carried out on cells
expressing either ABCB10-V5 or 35-ABCB10-V5. Wild-type
ABCB10-V5 appears as a major band corresponding to the mo-
lecular weight of the mature protein from which the mTP has
been cleaved (Fig. 3I). When SDS-PAGE is performed within 24 h
post-transfection, a faint, higher molecular weight band corre-
sponding to the approximate weight of the immature, uncleaved
protein is present (as seen in Fig. 1A). 35-ABCB10-V5 appears
as two bands of nearly equal strength, indicating that a substan-
tial fraction of the protein is left uncleaved. Since mitochondrial
presequences are known to be cleaved by enzymes located in the
mitochondrial matrix, significant amounts of 35-ABCB10-V5
probably fail to translocate across both mitochondrial mem-
branes. Extramitochondrial protein digestion by proteinase K
performed on isolated mitochondria results in the complete dis-
appearance of the high molecular weight 35-ABCB10-V5 band
and leaves the low molecular weight 35-ABCB10-V5 band un-
changed, supporting the role of aa 1–35 in the mitochondrial
import of ABCB10 into the inner membrane. Unlike 35-
ABCB10-V5, aa 36–105-EGFP does not significantly degrade in
the presence of proteinase K. This suggests that full mitochon-
drial insertion and proper presequence cleavage takes place.
Therefore, the downstream domain of ABCB10 (aa 106–715)
appears to present a challenge to mitochondrial import machin-
ery not found in EGFP alone. Although not essential for efficient
mitochondrial targeting, aa 1–35 is required for proper mitochon-
drial insertion.
Identification of Elements of the mTP Essential for Mito-
chondrial Targeting—A series of specific amino acid muta-
tion experiments were performed to elucidate the features of
aa 36–70 that are necessary for its mitochondrial targeting.
Mutations directed at removing arginine residues, disrupting
the predicted -helix, and replacing hydrophobic residues
were carried out. aa 36–70 contains two arginine residues at
positions 41 and 55, and these were mutated to alanine
individually and in tandem. Alanine possesses similar helix
formation properties to arginine, thereby limiting the effect
of arginine replacement to removing its positive charge. All
three mutants, R41A, R55A, and R41A/R55A, targeted EGFP
to mitochondria nearly as efficiently as wild-type: MMCC
values of 0.71  0.04, 0.76  0.03, and 0.74  0.03, respec-
tively (Table I). This was surprising in light of the presumed
importance of arginine in mTPs. aa 36–70 effectively targets
EGFP to the mitochondria with no arginine residues and a
single positively charged residue, Lys49.
To test the importance of the region’s -helix, the secondary
structure of aa 36–70 was disrupted. The predicted -helix of
aa 36–70 falls at aa 37–47. Mutating either Ala42 to Pro or
Arg41 to Pro is expected to destroy this conformation. Both
mutations were carried out, and neither significantly reduced
the mitochondrial targeting efficiency (Table I). The mTP of
ABCB10 therefore does not require a predictable -helix for
normal mitochondrial targeting.
The aa 36–70 fragment possesses considerable hydrophobic
character. We removed one hydrophobic residue pair with the
double mutation L46Q/I47Q. Glutamine residues were substi-
tuted for leucine and isoleucine to maintain the helix formation
and neutral charge properties of wild type. This mutation re-
sulted in drastic reduction in mitochondrial targeting of aa
36–70: MMCC 	 0.30  0.06 (Fig. 4A). The mitochondrial
targeting efficiency of aa 36–70 was reduced significantly fur-
ther with the addition of the R41A mutation (MMCC 	 0.15 
0.02), indicating that a threshold was breached that prevents
the ability of mTP to overcome the mutation of Arg41 (Fig. 4B).
The Addition of aa 1–35 and 71–105 to Hydrophobically
Mutated aa 36–70 Fails to Fully Rescue Mitochondrial Target-
ABCB10 does not significantly reduce mitochondrial targeting of either protein compared with wild-type mTP and wild-type ABCB10, respectively.
Bars in C–G, 20 m. H, Western blot of protein isolated from whole HEK 293T cells expressing EGFP alone (lane 1), aa 1–70-EGFP (lane 2), and
aa 1–105-EGFP (lane 3). Cleavage of EGFP occurs from aa 1–70-EGFP but not from aa 1–105-EGFP. I, Western blot of density gradient purified
mitochondria isolated from HEK 293T cells expressing ABCB10-V5 (lanes 1 and 2), 35-ABCB10-V5 (lanes 3 and 4), or aa 36–105-EGFP (lanes
5 and 6). The high molecular weight band in L3 is thought to be uncleaved protein, suggesting that the preprotein of 35-ABCB10-V5 did not reach
the mitochondrial matrix. Digestion of extramitochondrial proteins by proteinase K corroborates this finding. Of the three proteins, only
35-ABCB10-V5 is incompletely imported into the mitochondria. Loading of protein and localization of proteinase activity are controlled by probing
for porin, an abundant mitochondrial outer membrane protein. GFP, green fluorescent protein.
TABLE I
Recognized features of mTPs are not essential components of aa 36–70
Mutating neither arginine residues (alone or in tandem) nor the
predicted -helix significantly reduces the mitochondrial targeting of aa
36–70.
Mutation MMCC n
Wild type 0.77  0.02 12
aa 36–70-R41A 0.71  0.04 12
aa 36–70-R55A 0.76  0.03 12
aa 36–70-R41A-R55A 0.74  0.03 28
aa 36–70-R41P 0.73  0.02 19
aa 36–70-A42P 0.75  0.03 16
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ing—The flanking thirds of the mTP, aa 1–35 and 71–105, only
partially rescue the effect of the L46Q/I47Q mutations on aa
36–70, demonstrating that the Leu46-Ile47 hydrophobic pair of
the mTP of ABCB10 is essential for its mitochondrial targeting
(Fig. 4C). Since additional mutation of Arg41 to Ala in the
hydrophobic mutant results in no further decrease in mitochon-
drial targeting, the importance of the R41A mutation observed
in the aa 36–70 hydrophobic mutant is negated by the presence
of the flanking regions (Fig. 4, B and D).
Downstream (aa 106–715) Elements of ABCB10 Rescue Im-
paired Targeting of Mutated mTP—The internal domain of
ABCB10 (aa 106–715) completely restores mitochondrial tar-
geting of the mutated mTP. The R41A/L46Q/I47Q mutations
were carried out in full-length ABCB10 (715 aa) fused to EGFP
(Fig. 4E). The protein targeted to mitochondria as efficiently as
wild-type and at a significantly greater level than the mutated
105-aa mTP alone. Thus, internal regions of ABCB10, in addi-
tion to the mTP, possess mitochondrial targeting information.
ABCB10 Oligomerizes in the Inner Membrane—The mem-
brane-permeable cross-linker DFDNB was used to cross-link
endogenous ABCB10 in mitochondria isolated from differenti-
ating erythroid cells and V5 epitope-tagged ABCB10 in HEK
293T cells. When DFDNB was added, a band at 130 kDa, the
approximate mass of an ABCB10 homodimer, appeared and
strengthened in intensity with increasing amounts of DFDNB
over the range of 0.1–10 mg/mg of protein (Fig. 5A). The band
at65 kDa weakened with more DFDNB. The130-kDa band
similarly appeared when the mitochondrial preparation ex-
pressing ABCB10-V5 was run on SDS-PAGE in the absence of
-mercaptoethanol (Fig. 5B). A higher molecular mass band
(
200 kDa) also appeared with cross-linking, its intensity sim-
ilarly related to the concentration of DFDNB.
ABCB10 Forms Homodimers and Homo-oligomers—To de-
termine whether the ABCB10 complexes include ABCB10 ho-
FIG. 4. Mutating mitochondrial targeting elements of aa 1–35 identifies essential hydrophobic residues. A, mutating hydrophobic
residues Leu46-Ile47 significantly reduces mitochondrial targeting of aa 36–70 compared with wild type. B, the L46Q/I47Q mutant is additionally
susceptible to reduction of targeting efficiency by R41A mutation. The asterisk indicates significant difference from aa 36–70-L46Q/I47Q. C and
D, rejoining aa 1–35 and 71–105 to aa 36–70-L46Q/I47Q and aa 36–70-L46Q/I47Q/R41A partially restores mitochondrial targeting. The asterisks
indicate significant difference from mitochondrial targeting of wild-type aa 1–105. Therefore, rescue is incomplete. E, fusing aa 106–715 to aa
1–105-L46Q/I47Q/R41A restores mitochondrial targeting to that of wild-type ABCB10. Bars, 20 m.
Mitochondrial Targeting, Import, and Dimerization of ABCB1042960
 at M









modimers, HEK 293T cells were double transfected with both
V5 and c-Myc-tagged ABCB10. After isolating the mitochon-
dria and cross-linking as above, ABCB10 was immunoprecipi-
tated using anti-c-Myc antibody. The precipitated proteins
were separated by SDS-PAGE and Western blotted using
horseradish peroxidase-conjugated anti-V5 antibody. Bands
appeared at 65 and 130 kDa (Fig. 5C). This demonstrates
that both ABCB10 species, the c-Myc-tagged and the V5-
tagged, were components of some of the cross-linked complexes
and indicates that ABCB10 forms homodimers. The band at
65 kDa revealed that some ABCB10 complexes that had not
been cross-linked nevertheless co-immunoprecipitated intact
and ultimately were separated during SDS-PAGE. The anti-c-
Myc antibody was replaced with rabbit serum to verify immu-
noprecipitation specificity. Immunoprecipitated ABCB10-V5
from control and cross-linked samples were additionally probed
with silver stain (Fig. 5D). All bands identified under cross-
linking conditions (arrowheads) were subjected to MS/MS tryp-
tic fragment analysis. Only ABCB10 was identified in all
bands, suggesting that ABCB10 homo-oligomerizes and that no
other protein takes part in its quaternary structure assembly.
ER-targeted ABCB10 Forms Dimers—The quaternary struc-
ture assembly partners of ER-localized 105-ABCB10-EGFP
were examined in similar fashion. Cross-linking by DFDNB
and Western blotting was performed on whole cell lysates (Fig.
5E). 105-ABCB10-V5 appears to assemble into complexes
identical to those observed for wild-type ABCB10-V5. Thus, the
homodimerization of ABCB10 observed in mitochondria is nei-
ther organelle-specific nor mTP-dependent.
DISCUSSION
Mitochondrial ABC transporters play a key role in iron me-
tabolism and heme biosynthesis. Consisting of hydrophobic as
well as hydrophilic domains, ABC transporters may present a
challenge to mitochondrial import machinery. Four mamma-
lian mitochondrial transporters besides ABCB10 have been
discovered: ABC7, M-ABC1, M-ABC2, and MTABC3. ABC7,
M-ABC2, and M-ABC1 have been shown to possess mTPs (12,
30, 31). Computational analysis of MTABC3 predicts that it
does not possess an mTP and therefore is likely to enter the
mitochondrion via the Tom70 pathway. All mitochondrial ABC
transporters described to date are of the half-transporter type
and therefore predicted to dimerize; however, their dimeriza-
tion partners have not yet been identified. We report here the
first comprehensive analysis and characterization of the import
of a mitochondrial ABC transporter, ABCB10, and its assembly
into a homodimer in the inner membrane. We applied com-
bined microscopy and cellular fractionation to study the func-
tion of different components of the mTP in trafficking, import,
and dimerization of ABCB10. Taking this approach, we show
that whereas the middle segment of the mTP contains hydro-
phobic residues essential for trafficking of the protein to the
organelle, the N-terminal subdomain is necessary for proper
insertion of the protein into the organelle. Further, we show
that ABCB10 homodimerizes in the inner membrane and can
similarly assemble into dimers in the ER when expressed with-
out the mTP.
We determined that the mTP of ABCB10 is sufficient for
mitochondrial import of EGFP and that the middle fragment
(aa 36–70) contains the minimal information necessary to
direct these processes. Net positive charge, derived particu-
larly from arginine residues, and amphiphilic -helices are
thought to play important roles in the mitochondrial target-
ing properties of mTPs (14, 17). Removal of these elements by
mutation in aa 36–70-EGFP results in wild-type phenotype.
We therefore speculate that certain mTPs possess flexible
and redundant mitochondrial targeting properties that allow
FIG. 5. Quaternary structure assembly of ABCB10. A, lanes 1
and 2, Western blot of mitochondria isolated from wild-type G1ER cells,
in the absence (lane 1) and presence (lane 2) of cross-linker DFDNB
(CL), probed with anti-ABCB10. The ABCB10 monomer at 65 kDa
diminishes in the presence of DFDNB, and a new band at 130 kDa
appears. The band at 95 kDa is a cross-reactivity artifact of this
antibody. Note that this artifact is unaffected by DFDNB, demonstrat-
ing the cross-linker’s specificity. Lanes 3–5, Western blot of mitochon-
dria harvested from HEK 293T cells expressing V5-tagged ABCB10 and
probed with anti-V5-horseradish peroxidase (HRP) antibody. Increas-
ing DFDNB concentration from 0.1 mg/mg of protein (lane 4) to 10
mg/mg of protein (lane 5) results in more complete cross-linking of
ABCB10 monomers. B, Western blot of mitochondria isolated from HEK
293T cells expressing ABCB10-V5. SDS-PAGE in the absence of reduc-
ing agent -mercaptoethanol (B-ME; lane 2) preserves higher molecular
weight ABCB10 complexes. C, Western blot of mitochondria harvested
from HEK 293T cells co-transfected with ABCB10-V5 and ABCB10-c-
Myc. Detection using anti-V5-horseradish peroxidase followed chemical
cross-linking by DFDNB and immunoprecipitation (IP) with anti-c-
Myc. Control for immunoprecipitation (lanes 4 and 5) used antibody-
free serum in place of anti-c-Myc antibody. D, silver stain of immuno-
precipitated ABCB10-V5 from control (lane 1) and cross-linked (lane 2)
mitochondria of HEK 293T cells. Bands in lane 2 marked with arrow-
heads were excised and identified using MS/MS tryptic fragment anal-
ysis. The star-marked band at 60 kDa is an artifact of the anti-V5
antibody used for immunoprecipitation. E, Western blot of whole cell
protein isolated from HEK 293T cells transfected with 105-ABCB10-
V5. The addition of DFDNB (lane 2) results in a shift of monomeric
ABCB10 to complexes consistent in weight with homodimers of
ABCB10.
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them to bypass the use of conventional targeting mecha-
nisms. Further mutation experiments identified two key hy-
drophobic residues that are essential for efficient mitochon-
drial targeting. A hydrophobic pentapeptide motif has been
identified as essential for recognition by the TOM complex
both in vitro and in vivo (18, 19). This motif occurs three
times in aa 36–70, one of which includes Leu46-Ile47. Mutat-
ing these residues to glutamine destroyed most of the mito-
chondrial targeting of aa 36–70 and left the peptide suscep-
tible to additional reduction in targeting efficiency by
arginine replacement. This indicates that, like plant F1-ATP
synthase (18), ABCB10 associates with Tom20 via hydropho-
bic interactions, as described by Abe et al. (32). Fusing the
flanking regions of the mTP to aa 36–70 failed to completely
rescue the effect rendered by the hydrophobic mutations yet
did attenuate the additional insult imparted by the R41A
mutation. This suggests that the distribution of positive
charge in the mTP of ABCB10 has margin for error, support-
ing its role as a provider of thermodynamic energy for trans-
location and not for precise recognition and binding with
import machinery (33). On the contrary, the hydrophobic
residues responsible for Tom20 interaction must meet strin-
gent accessibility and location requirements, since all nine
additional hydrophobic pentapeptide motifs of the aforemen-
tioned type introduced by the flanking regions failed to com-
pletely rescue the L46Q/I47Q mutation. Fusion of the inter-
nal region of ABCB10, aa 106–715, to the hydrophobically
mutated 105-aa mTP fully rescued mitochondrial targeting.
This implies that ABCB10 contains internal signals that
provide targeting information in addition to the mTP. This
has been observed in the inner membrane protein cytochrome
c1 but is a relatively rare feature of nuclear encoded mito-
chondrial proteins (34). Although the hydrophobically mu-
tated mTP and the internal domain independently are inca-
pable of targeting EGFP to the mitochondria, their union
creates an efficiently targeted protein (without the introduc-
tion of a necessary targeting element at their junction). A
similar phenomenon was demonstrated by Galanis et al. (35),
who by doubling a mitochondrial presequence increased its
targeting potency. Considering the challenge to mitochon-
drial import that ABCB10 presents, the protein is an ideal
candidate for possessing redundant import features.
To determine whether aa 1–35 improves mitochondrial tar-
geting by providing additive information to the targeting prop-
erties of aa 36–70, aa 1–70-EGFP was constructed; however,
the resulting protein was unstable. This demonstrates the po-
tential instability of EGFP-tagged proteins and the necessity to
verify that unanticipated cleavage does not occur. Instead, we
assessed the effect that the absence of aa 1–35 had on targeting
efficiency by constructing 35-ABCB10-EGFP/V5. Fluores-
cence microscopy found that the absence of aa 1–35 does not
significantly reduce mitochondrial targeting of ABCB10-EGFP.
However, proteinase K digestion of extramitochondrial pro-
teins found that translocation of 35-ABCB10-V5 across the
mitochondrial membrane is reduced, indicating that the pro-
cesses of mitochondrial targeting and import can be separated.
aa 1–35, although necessary for proper mitochondrial import of
ABCB10-V5, is not required for that of EGFP, a purely hydro-
philic protein. Thus, the distinction between mitochondrial
trafficking and import may be more easily observed in proteins
that challenge the trafficking/import machinery. The mecha-
nism by which aa 1–35 directs the mitochondrial import of
ABCB10 is potentially related to a number of characteristics of
ABCB10 and the import machinery. Since mitochondrial pro-
teins are predicted to enter the mitochondria either through a
linear or loop conformation, depending on the import pathway,
aa 1–35 may affect the folding of ABCB10 and thereby influ-
ence the pathway selected (13, 36). Since each mitochondrial
membrane possesses its unique import machinery, aa 1–35
may be specifically required for import across the inner mem-
brane but not the outer. Mislocalization of imported proteins
among the mitochondrial compartments has been demon-
strated in cytochrome c oxidase subunit Va (37). Alternatively,
aa 1–35 might simply add import elements needed to overcome
a threshold, similar to the additive targeting properties ob-
served in ABCB10. Further investigation will help to tease
apart mitochondrial trafficking and import mechanisms and
explain the obstacles that ABCB10 presents to each.
ABCB10 lacking its 105-aa mTP efficiently localizes to the
ER, raising the possibility that an isoform of ABCB10 is pres-
ent in the ER under physiological conditions or when the start
codon is mutated. A number of proteins have been described
that employ alternate splicing or post-translational modifica-
tion to direct ER or mitochondria-specific targeting as required.
cAMP-dependent phosphorylation orchestrates the redirection
of cytochromes to either the ER or mitochondria in response to
cellular signaling cascades (38). Alternate splicing of D-AKAP1
results in its tissue-specific localization in either the ER or the
mitochondria (29). Similarly, use of an alternate transcrip-
tional start site for cytochrome P450 monooxygenase redirects
this predominantly ER protein to mitochondria in the liver and
extrahepatic tissues (39). Although alternative splice variants
of ABCB10 have not yet been identified, the availability of
additional, in-frame transcriptional start sites at amino acid
positions 151 and 201 and preliminary 5 RACE results (data
not shown) lead us to suspect their presence. Computational
analysis (Target P and PSORTII) of the targeting properties of
the putative secondary start site isoform strongly predicts ER
localization. With time (
24 h) after transfection of 105-
ABCB10-EGFP, the ER undergoes morphological change.
Studies by van Leeuwen et al. (40) suggest that ER stress may
result from a mistargeted protein functioning in the ER. De-
pletion or accumulation of substrate within the ER by ABCB10
could cause damage to the organelle. This would imply that
ABCB10 is functional in the ER, is oriented in a consistent
fashion, and exists with any necessary assembly partners.
ABCB10 is of the half-transporter type as described by Hig-
gins (1). Dimerization of ABC half-transporters has been
shown to be necessary to achieve functionality (6, 41) and has
been observed in many ABC proteins. Homodimerization has
been observed in ABC transporters of the plasma membrane (6)
and peroxisome (4), and homo-oligomerization by several mo-
nomeric subunits has recently been demonstrated in ABCG2
(42). Among mitochondrial ABC transporters, Mdl1 and M-
ABC1 have been shown to oligomerize, but their partners re-
main unidentified (30, 43). We sought to elucidate the assembly
partners, if any, of ABCB10 using a chemical cross-linking
methodology. DFDNB, an amino-reactive noncleavable cross-
linker with a short spacer arm (3 Å), has been employed
previously for protein structure studies (44). We used it here to
identify assembly partners of ABCB10 that are not preserved
using conventional SDS-PAGE techniques. Co-transfection and
immunoprecipitation experiments of cross-linked mitochon-
drial preparations found that the dimerization partner for
ABCB10 is an additional ABCB10 monomer. Mass spectrome-
try analysis of immunopurified ABCB10 complexes verified
that ABCB10 homodimerizes and homo-oligomerizes in mito-
chondria and indicated that other proteins do not intimately
co-assemble with ABCB10. Nonreducing SDS-PAGE suggests
that the homodimer is stabilized through disulfide bonds, in-
dicating that the dimeric association is sufficiently close to
allow covalent bonding. Whether these bonds are natural or
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artificial is unknown, for it was recently reported that oxida-
tion during sample preparation may cause disulfide bond for-
mation between dimeric units (42). Since no additional proteins
intimately co-assemble with ABCB10, homo-oligomers of
ABCB10 may themselves achieve functionality. Interestingly,
homo-oligomerization of 105-ABCB10 appears to occur in the
ER equally as efficiently as wild-type, mitochondria-localized
ABCB10, suggesting that the process does not require the mTP
of ABCB10 or any mitochondria-specific chaperones.
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